Zobrazeno 1 - 3
of 3
pro vyhledávání: '"E. S. Sena"'
Autor:
P. P. Zwetsloot, L. H. J. A. Kouwenberg, E. S. Sena, J. E. Eding, H. M. den Ruijter, J. P. G. Sluijter, G. Pasterkamp, P. A. Doevendans, I. E. Hoefer, S. A. J. Chamuleau, G. P. J. van Hout, S. J. Jansen of Lorkeers
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-1 (2018)
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
Externí odkaz:
https://doaj.org/article/2b03aeaaaac5436981f91d36c4d6567c
Autor:
P. P. Zwetsloot, L. H. J. A. Kouwenberg, E. S. Sena, J. E. Eding, H. M. den Ruijter, J. P. G. Sluijter, G. Pasterkamp, P. A. Doevendans, I. E. Hoefer, S. A. J. Chamuleau, G. P. J. van Hout, S. J. Jansen of Lorkeers
Publikováno v:
Scientific Reports, 7(1). Nature Publishing Group
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Zwetsloot, P P, Kouwenberg, L H J A, Sena, E S, Eding, J E, Den Ruijter, H M, Sluijter, J P G, Pasterkamp, G, Doevendans, P A, Hoefer, I E, Chamuleau, S A J, Van Hout, G P J & Jansen Of Lorkeers, S J 2017, ' Optimization of large animal MI models; a systematic analysis of control groups from preclinical studies ', Scientific Reports, vol. 7, no. 1 . https://doi.org/10.1038/s41598-017-14294-z
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Zwetsloot, P P, Kouwenberg, L H J A, Sena, E S, Eding, J E, Den Ruijter, H M, Sluijter, J P G, Pasterkamp, G, Doevendans, P A, Hoefer, I E, Chamuleau, S A J, Van Hout, G P J & Jansen Of Lorkeers, S J 2017, ' Optimization of large animal MI models; a systematic analysis of control groups from preclinical studies ', Scientific Reports, vol. 7, no. 1 . https://doi.org/10.1038/s41598-017-14294-z
Scientific Reports
Large animal models are essential for the development of novel therapeutics for myocardial infarction. To optimize translation, we need to assess the effect of experimental design on disease outcome and model experimental design to resemble the clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3b7478ec5bade973eec7c5519b0df41
https://dspace.library.uu.nl/handle/1874/356640
https://dspace.library.uu.nl/handle/1874/356640
Autor:
S. J. Jansen Of Lorkeers, J. E. C. Eding, T. I. G. Van Der Spoel, H. M. Vesterinen, S. Koudstaal, E. S. Sena, P. A. Doevendans, M. R. Macleod, S. A. J. Chamuleau
Publikováno v:
European Heart Journal. 34:P1462-P1462
Introduction: In regenerative therapy for ischemic heart disease use of both autologous and allogeneic stem cells have been investigated. An important drawback of autologous cell therapy is the restricted availability, especially in the acute setting